CA2839606A1 - Indene derivatives for use in the treatment of inflammatory bowel disease - Google Patents

Indene derivatives for use in the treatment of inflammatory bowel disease Download PDF

Info

Publication number
CA2839606A1
CA2839606A1 CA2839606A CA2839606A CA2839606A1 CA 2839606 A1 CA2839606 A1 CA 2839606A1 CA 2839606 A CA2839606 A CA 2839606A CA 2839606 A CA2839606 A CA 2839606A CA 2839606 A1 CA2839606 A1 CA 2839606A1
Authority
CA
Canada
Prior art keywords
compound
tert
mice
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2839606A
Other languages
English (en)
French (fr)
Inventor
Helen Sheridan
Neil Frankish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Venantius Ltd
Original Assignee
Venantius Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Venantius Ltd filed Critical Venantius Ltd
Publication of CA2839606A1 publication Critical patent/CA2839606A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
CA2839606A 2011-07-22 2012-07-20 Indene derivatives for use in the treatment of inflammatory bowel disease Abandoned CA2839606A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161510628P 2011-07-22 2011-07-22
US61/510,628 2011-07-22
PCT/IE2012/000037 WO2013014659A1 (en) 2011-07-22 2012-07-20 Indene derivatives for use in the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
CA2839606A1 true CA2839606A1 (en) 2013-01-31

Family

ID=46584089

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2839606A Abandoned CA2839606A1 (en) 2011-07-22 2012-07-20 Indene derivatives for use in the treatment of inflammatory bowel disease

Country Status (11)

Country Link
US (1) US9586885B2 (OSRAM)
EP (1) EP2734496A1 (OSRAM)
JP (1) JP5898768B2 (OSRAM)
CN (1) CN103764608B (OSRAM)
AU (1) AU2012288404A1 (OSRAM)
BR (1) BR112014001551A2 (OSRAM)
CA (1) CA2839606A1 (OSRAM)
NZ (1) NZ618936A (OSRAM)
RU (1) RU2601307C2 (OSRAM)
TW (1) TWI537246B (OSRAM)
WO (1) WO2013014659A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734497A1 (en) * 2011-07-22 2014-05-28 Venantius Limited Indane dimers for use in the treatment of autoimmune inflammatory disease
CN110426464B (zh) * 2019-07-08 2022-03-04 苏州正济药业有限公司 一种葡甲胺中异构体的hplc检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246670T1 (de) * 1995-12-06 2003-08-15 Venantius Ltd Indandimerverbindungen mit relaxierender wirkung auf die glatten muskeln und/oder mit mastzellen stabilisiernder und/oder entzuendungshemmender wirkung
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
AU3899097A (en) * 1996-08-05 1998-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted aromatic compounds
US20020128256A1 (en) * 1997-11-20 2002-09-12 Carlo Brugnara Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation
IL136208A0 (en) * 1997-11-20 2001-05-20 Childrens Medical Center Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours
EP1307455B1 (en) * 1999-10-20 2005-04-06 Tanabe Seiyaku Co., Ltd. Inhibitors of alpha-l beta-2 mediated cell adhesion
CA2521883C (en) 2003-04-15 2013-09-17 Inflazyme Pharmaceuticals Ltd. Indene derivatives as pharmaceutical agents
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
EP2734497A1 (en) 2011-07-22 2014-05-28 Venantius Limited Indane dimers for use in the treatment of autoimmune inflammatory disease
WO2013174917A1 (en) 2012-05-24 2013-11-28 Venantius Limited Compounds for use in the treatment of autoimmune inflammatory disease
US20150141506A1 (en) 2012-05-24 2015-05-21 Venantius Limited Indane dimers for use in the treatment of autoimmune inflammatory disease

Also Published As

Publication number Publication date
RU2601307C2 (ru) 2016-11-10
JP2014524921A (ja) 2014-09-25
WO2013014659A1 (en) 2013-01-31
US9586885B2 (en) 2017-03-07
CN103764608A (zh) 2014-04-30
EP2734496A1 (en) 2014-05-28
AU2012288404A1 (en) 2014-01-09
BR112014001551A2 (en) 2017-06-13
US20140128466A1 (en) 2014-05-08
CN103764608B (zh) 2016-02-03
TW201311637A (zh) 2013-03-16
RU2013155270A (ru) 2015-08-27
JP5898768B2 (ja) 2016-04-06
TWI537246B (zh) 2016-06-11
HK1196597A1 (zh) 2014-12-19
NZ618936A (en) 2015-07-31

Similar Documents

Publication Publication Date Title
JP7519102B2 (ja) カンナビノイドの共結晶の固体組成物
JP2005535712A (ja) レソルビン：治療処置用のバイオテンプレート
CA2615077A1 (en) Use of 3,1ib-cis-dihydrotetrabenazine for the treatment of symptoms of huntington's disease
TW201309666A (zh) 一種取代桂皮醯胺衍生物、製備方法及其應用
JP2019523245A (ja) オーファン核内受容体Ｎｕｒ７７のリガンド及びその使用
US5786380A (en) VPA-analogous antiepileptics
US9586885B2 (en) Compounds for use in the treatment of inflammatory bowel disease
US7019034B2 (en) Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals
TW200305399A (en) 4-[(8-Substituted)-6-chromanoyl]-and 4-[8-(substituted)-chroman-6-yl-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity
JPH05502243A (ja) ３―置換及び３，３―ジ置換４―オキソレチノイン酸及びそれらのエステル
EP2734497A1 (en) Indane dimers for use in the treatment of autoimmune inflammatory disease
US9260376B2 (en) Compounds for use in the treatment of immune related inflammatory disease
CN101821229B (zh) 三环类胺化合物
EP2855416A1 (en) Indane dimers for use in the treatment of autoimmune inflammatory disease
EP2346804A1 (en) Compositions comprising cb receptor agonists, uses thereof and methods for their preparation
JP4345311B2 (ja) 抗酸化剤
HK1196597B (en) Indene derivatives for use in the treatment of inflammatory bowel disease
CN103260614B (zh) 联合疗法
US10799496B2 (en) Naphthylenyl compounds for long-acting injectable compositions and related methods
AU761572B2 (en) 5,6-dihydronaphthalenyl derivatives having retinoid-like activity
WO2020094634A1 (en) Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods
RU2173683C2 (ru) Ретиноиды и фармацевтическая композиция, их содержащая
JPH11514383A (ja) 神経保護活性を有するチアモルヒナン
CN111727039A (zh) 大肠炎改善剂
JPH051004A (ja) 安息香酸誘導体

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180720